StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.58+0.82 (+6.43%)

Close on Nov 17, 2026Market cap $476.21MP/E –Yield –

Fennec Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Fennec Pharmaceuticals's pe ratio was 109.0× on Oct 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 2024109.0×–

More Fennec Pharmaceuticals figures

See a number that looks wrong?